BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22492709)

  • 1. Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve.
    Srinivasan R; Sun G; Keles S; Jones EA; Jang SW; Krueger C; Moran JJ; Svaren J
    Nucleic Acids Res; 2012 Aug; 40(14):6449-60. PubMed ID: 22492709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes.
    Jang SW; Srinivasan R; Jones EA; Sun G; Keles S; Krueger C; Chang LW; Nagarajan R; Svaren J
    J Neurochem; 2010 Dec; 115(6):1409-20. PubMed ID: 21044070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic regulation of Schwann cell enhancers after peripheral nerve injury.
    Hung HA; Sun G; Keles S; Svaren J
    J Biol Chem; 2015 Mar; 290(11):6937-50. PubMed ID: 25614629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo detection of Egr2 binding to target genes during peripheral nerve myelination.
    Jang SW; LeBlanc SE; Roopra A; Wrabetz L; Svaren J
    J Neurochem; 2006 Sep; 98(5):1678-87. PubMed ID: 16923174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10.
    LeBlanc SE; Ward RM; Svaren J
    Mol Cell Biol; 2007 May; 27(9):3521-9. PubMed ID: 17325040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells.
    Reiprich S; Kriesch J; Schreiner S; Wegner M
    J Neurochem; 2010 Feb; 112(3):744-54. PubMed ID: 19922439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements.
    Jang SW; Svaren J
    J Biol Chem; 2009 Jul; 284(30):20111-20. PubMed ID: 19487693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct regulation of myelin protein zero expression by the Egr2 transactivator.
    LeBlanc SE; Jang SW; Ward RM; Wrabetz L; Svaren J
    J Biol Chem; 2006 Mar; 281(9):5453-60. PubMed ID: 16373334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression.
    Marathe HG; Mehta G; Zhang X; Datar I; Mehrotra A; Yeung KC; de la Serna IL
    PLoS One; 2013; 8(7):e69037. PubMed ID: 23874858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COUP-TFII plays a role in cAMP-induced Schwann cell differentiation and in vitro myelination by up-regulating Krox20.
    Han SH; Kim YH; Park SJ; Cho JG; Shin YK; Hong YB; Yun J; Han JY; Park HT; Park JI
    J Neurochem; 2023 Jun; 165(5):660-681. PubMed ID: 36648143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active gene repression by the Egr2.NAB complex during peripheral nerve myelination.
    Mager GM; Ward RM; Srinivasan R; Jang SW; Wrabetz L; Svaren J
    J Biol Chem; 2008 Jun; 283(26):18187-97. PubMed ID: 18456662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the PMP22 gene through an intronic enhancer.
    Jones EA; Lopez-Anido C; Srinivasan R; Krueger C; Chang LW; Nagarajan R; Svaren J
    J Neurosci; 2011 Mar; 31(11):4242-50. PubMed ID: 21411665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egr2-dependent microRNA-138 is dispensable for peripheral nerve myelination.
    Lin HP; Oksuz I; Svaren J; Awatramani R
    Sci Rep; 2018 Feb; 8(1):3817. PubMed ID: 29491350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination.
    Leblanc SE; Srinivasan R; Ferri C; Mager GM; Gillian-Daniel AL; Wrabetz L; Svaren J
    J Neurochem; 2005 May; 93(3):737-48. PubMed ID: 15836632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression.
    Nagarajan R; Svaren J; Le N; Araki T; Watson M; Milbrandt J
    Neuron; 2001 May; 30(2):355-68. PubMed ID: 11394999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
    Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
    Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
    Domènech-Estévez E; Baloui H; Meng X; Zhang Y; Deinhardt K; Dupree JL; Einheber S; Chrast R; Salzer JL
    J Neurosci; 2016 Apr; 36(16):4506-21. PubMed ID: 27098694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities.
    Ghislain J; Charnay P
    EMBO Rep; 2006 Jan; 7(1):52-8. PubMed ID: 16311519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of myelinating Schwann cells and barrier integrity between central and peripheral nervous systems depend on Sox10.
    Fröb F; Bremer M; Finzsch M; Kichko T; Reeh P; Tamm ER; Charnay P; Wegner M
    Glia; 2012 May; 60(5):806-19. PubMed ID: 22337526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.